RARγ promotes the invasion and metastasis of thyroid carcinoma by activating the JAK1-STAT3-CD24/MMPs axis

Int Immunopharmacol. 2023 Dec;125(Pt A):111129. doi: 10.1016/j.intimp.2023.111129. Epub 2023 Oct 27.

Abstract

The nuclear receptor superfamily RAR is generally considered to play a crucial role in the development of tumors by regulating the transcription of target genes. Nevertheless, whether RARγ performs tumor-promoting or tumor-suppressing functions and its specific mechanism in thyroid carcinoma (TC) remain unknown. Here, our study demonstrated that RARγ was abnormally overexpressed in TC tissues compared with normal thyroid tissues. Moreover, RARγ expression was remarkably correlated with cell phenotypes such as cell proliferation, migration and invasion. Mechanistically, RARγ knockdown effectively decreased the phosphorylation levels of JAK1 and STAT3, leading to decreased expression of the membrane protein CD24. In a coculture system, TC cells with high levels of CD24 in the membrane were more likely to escape phagocytosis by macrophages via the combination of CD24 with the inhibitory receptor Siglec-10 in the membrane of macrophages. In contrast, the ability of macrophages to engulf TC cells was notably elevated through exogenous addition of CD24 antibody. Collectively, our study revealed a previously undiscovered molecular mechanism of RARγ in promoting the development of TC, shedding light on RARγ as a promising therapeutic target for TC.

Keywords: CD24; JAK1-STAT3 signalling pathway; Macrophages; Metastasis; RARγ; Thyroid carcinoma.

MeSH terms

  • CD24 Antigen
  • Cell Line, Tumor
  • Cell Proliferation
  • Humans
  • Janus Kinase 1
  • Retinoic Acid Receptor gamma
  • STAT3 Transcription Factor
  • Thyroid Neoplasms* / genetics

Substances

  • CD24 Antigen
  • CD24 protein, human
  • JAK1 protein, human
  • Janus Kinase 1
  • STAT3 protein, human
  • STAT3 Transcription Factor